Navigation Links
KV Pharmaceutical Company Comments on Legal Development in Its Branded Pharmaceutical Business
Date:6/10/2008

ST. LOUIS, June 10 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology-differentiated branded products and generic/non-branded prescription pharmaceuticals, today reported that it has become aware of litigation filed by a smaller generic drug company, Lannett Company, Inc., challenging the patent rights associated with PrimaCare ONE(R), a prenatal vitamin product marketed by KV's Ther-Rx branded pharmaceutical business unit. KV has not yet been served in the lawsuit.

"We are reviewing the claims in this lawsuit and we will defend this and any other challenge to our patent rights vigorously," stated Marc S. Hermelin, KV's Chairman of the Board and Chief Executive Officer. "Our long-standing expertise in the development and marketing of both branded and generic/unbranded products positions us well to aggressively defend this type of lawsuit, which is not uncommon in our industry. In addition, we will continue to pursue various other strategies to meet the needs of patients in the therapeutic categories we serve with innovative and cost-effective products."

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technology- distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded prescription pharmaceutical subsidiary.

For further information about KV Pharmaceutical Company, please visit the Company's corporate website at http://www.kvpharmaceutical.com.

Safe Harbor

The information in this release may contain va
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
2. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
3. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
4. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
5. Amira Pharmaceuticals Hires Industry Veteran for CFO Position
6. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
7. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
8. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
9. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
10. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
11. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... concept demonstration tires made with BioIsoprene technology, ... in the manufacture of synthetic rubber with renewable biomass, ... tire will be on display at a lounge in ... throughout December 21, while the other tire will make ...
(Date:12/2/2009)... - "Bolstering Biodiversity in Africa: ... Coinciding with the International Year of Biodiversity, ... international conference in Libreville,(Gabon) on the issue of ... attended by government and state leaders, ministers,scientific experts, ...
(Date:12/2/2009)... December 2 Gamida Cell announced today,a feasibility ... of a gene therapy product which combines technology ... product may have potential to,treat inherited anemias such ... Gamida Cell is developing a series of technologies ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Libreville International Conference 2-3 June 2010 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
... June 19 deCODE genetics,(Nasdaq: DCGN ) today ... deCODE,CEO Kari Stefansson,s presentation at the Piper Jaffray Europe ... June 25, at 7am,Eastern Time/11am GMT/12 noon British Summer ... be accessed through the Investors page on deCODE,s,website, ...
... on Friday, June 20, 2008, NEW YORK, June ... plaintiffs, litigation law firms in America, filed a lawsuit ... York City Fire,Department Emergency Medical Technician whose diabetes was ... Armstead, was one,of the many brave responders on the ...
... TRIANGLE PARK, N.C., June 19 Quintiles,Transnational Corp. ... Global,Marketing and Chief Marketing Officer and David Coman ... Patient Recruitment., "Both Dave and Millie bring ... in marketing and communication," said Mike Mortimer,Chief Administrative ...
Other Biology Technology:deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference 2deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference 3Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca 2Quintiles Appoints New Executives 2
(Date:12/3/2009)... year, the CTRC-AACR San Antonio Breast Cancer Symposium continues ... world leaders from industry and academia with the goal ... than 8,500 scientists and other professionals will gather at ... from Dec. 9-13, 2009. The symposium is a partnership ...
(Date:12/3/2009)... Mich. (Dec. 3, 2009) Van Andel Research ... abscisic acid (ABA) works at the molecular level to help ... Their findings, published in the journal Nature , ... the world and combat global food shortages. The findings ...
(Date:12/3/2009)... by a social snubbing? Your genetics, not your friends, may ... painkillers, called opioids, relieve not only physical pain, but also ... by Faculty of 1000 Biology member Markus Heilig shows that ... can determine the intensity of people,s responses to social rejection. ...
Breaking Biology News(10 mins):CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 321 Regional Hospitals Recognized as Nations Most Wired 50941 121 Regional Hospitals Recognized as Nations Most Wired 50941 221 Regional Hospitals Recognized as Nations Most Wired 50941 3Knowing Yourself Can Improve Your Health and Happiness 50937 1Knowing Yourself Can Improve Your Health and Happiness 50937 2Knowing Yourself Can Improve Your Health and Happiness 50937 3Family History Key to Psychiatric Disorder Risk 50934 1Family History Key to Psychiatric Disorder Risk 50934 2
... has shown promise in skin disease and hemophilia might one ... new study by researchers at Stanford University School of Medicine. ... the Proceedings of the National Academy of Sciences the week ... a healthy copy of the gene dystrophin into mice with ...
... Scientists at New York University School of Medicine report in ... that turns on the production of myelin, the fatty insulation ... the nervous system. The study, published in the September 1, ... avenue for treating nervous system diseases such as multiple sclerosis, ...
... ScienceJust as hurricanes in the Gulf states and Guatemala ... Harvard Medical School have identified a new type of ... bacteria outright by interfering with processes essential for their ... that cause the severe diarrhea associated with Vibrio cholerae ...
Other Biology News:Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 2Gene therapy for muscular dystrophy fixes frail muscle cells in animal model, Stanford study finds 3Scientists discover the molecular switch for nerve cells' insulating jelly rolls 2